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Myocardial Assessment in School-Aged Children with Past 
Kawasaki Disease
Coronary artery involvement remains the most important complication with Kawasaki 
disease (KD). Additional myocardial injury can be caused by inflammatory response and 
ischemic event. However, the long-term outcome of myocardial function has not been 
fully known in KD. The purpose of this study is to evaluate myocardial function in school-
aged children who had the past history of KD. Sixty-seven children in the second grade of 
elementary schools, who had the past history of KD, were included. Echocardiographic 
measurements of each coronary artery and myocardial function were obtained as the long-
term follow-up data, and compared with the baseline data at the time of initial 
presentation of KD. The mean age of the subjects was 8.6 ± 2.4 years, and 4.3 ± 3.4 years 
have passed since the diagnosis of KD. Among the echocardiographic data, interventricular 
septum thickness at end-diastole (IVSd), LV internal diameters at end-systole (LVIDs), 
maximal velocity of late diastolic filling across mitral valve (mitral A) flow, maximal velocity 
of early diastolic filling across mitral valve (mitral E)/A ratio, mitral inflow E wave to peak 
early diastolic tissue velocity (E/E’) ratio showed significant differences between the baseline 
and follow-up measurements. Coronary Z-score of left main artery (LMA), left anterior 
descending (LAD), and right coronary artery (RCA) showed no significant difference. The 
school-aged children with the past history of KD may have diastolic dysfunction. 
Therefore, appropriate assessment of myocardial function would be recommended during 
the follow-up period in children with KD.
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INTRODUCTION
Kawasaki disease (KD) is a systemic vasculitis first described by 
Kawasaki in 1967 (1). KD is the leading cause of acquired heart 
diseases in childhood. Coronary arteriopathy is the most im-
portant complications of KD, ranging from no invasion to mul-
tiple giant coronary aneurysms (2). The Japanese Ministry of 
Health criteria defines coronary arteriopathy as a maximum in-
ternal diameter > 3 mm in children < 5 years of age and > 4 
mm in children > 5 years, or a segment of > 1.5 times greater 
than the adjacent segments, or the presence of luminal irregu-
larity. Coronary aneurysms occur in 15%–25% of untreated pa-
tients; and 2%–3% of untreated patients die from coronary arte-
riopathy (3). The American Heart Association proposed that 
patients with KD receive the therapeutic and follow-up man-
agements according to the degree of coronary involvement (2,4). 
The American Heart Association’s proposal classifies the thera-
peutic managements into the five risk levels depending on the 
degree of coronary involvement: 1) risk level I, no coronary ab-
normalities at any time of KD; 2) risk level II, transient coronary 
artery ectasia or dilatation; 3) risk level III, solitary small-to-me-
dium-sized (3–6 mm) coronary artery aneurysm in one or more 
coronary arteries; 4) risk level IV, one or more large (> 6 mm) or 
giant ( > 8 mm) coronary artery aneurysm and/or multiple or 
complex coronary aneurysms without obstruction; and 5) risk 
level V, coronary artery obstruction and/or myocardial ischemia.
 Moreover, other cardiac complications may occur in KD. Myo-
carditis and valvulitis may occur, resulting in abnormal func-
tion of myocardium and cardiac valves. Myocarditis may occur 
in up to 50% of patients with KD. Myocardial injury can be devi-
ded into two types: inflammatory and ischemic lesions. Inter-
stitial myocarditis and pericarditis are the inflammatory lesion 
with neutrophilic predominance. Coronary aneurysms and mi-
crocirculatory disorders may cause ischemic myocardial dam-
age, and the patients with ischemic myocardial damage may 
have cardiac wall motion abnormalities that can be confirmed 
by echocardiography (2).
 There are previous studies on the systolic or diastolic dysfunc-
tion in acute KD. However, the long-term outcome of myocar-
dial function has not been fully known in KD. The purpose of 
this study is to evaluate myocardial function in school-aged chil-
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MATERIALS AND METHODS
Patient characteristics
This is a retrospective study on the children who visited the pe-
diatric cardiac outpatient clinic of Gangnam Severance Hospi-
tal from January 2013 to December 2015, and had the past his-
tory of KD. Sixty-seven patients in the second grade of elemen-
tary schools were included in this study. Echocardiographic 
measurements of each coronary artery and myocardial func-
tion were obtained as the long-term follow-up data, and com-
pared with the baseline data at the time of initial presentation 
of KD.
Echocardiography and coronary artery measurement
All patients were diagnosed with cardiac lesions based on find-
ings from two-dimensional echocardiography with spectral 
Doppler and tissue Doppler examination. We used the diag-
nostic criteria for cardiac lesions in KD defined by the Japanese 
Ministry of Health (5). The internal diameters of coronary arte-
rial segments were measured from inner edge to inner edge. 
The right coronary artery (RCA) and left anterior descending 
coronary artery were measured 3 to 5 mm distal to their origins 
in the parasternal short-axis view (6). Routinely examined car-
diac structures, including valves, left ventricular (LV) internal 
diameters at end-diastole (LVIDd), LV internal diameters at 
end-systole (LVIDs), LV ejection fraction (LVEF), LV fraction 
shortening (LVFS), interventricular septum thickness (IVS) and 
LV posterior wall thickness (LVPW), were also measured ac-
cording to the guidelines and standards for performance of pe-
diatric echocardiogram by the Amedican Society of Echocar-
diography (7).
Equation of coronary artery Z-score
Coronary arterial diameters were normalized for the body sur-
face area (BSA) as Z-scores (standard deviations [SDs] from a 
predicted normal mean) based on non-linear regression equa-
tions derived from a normal non-febrile population. The BSA 
was computed by the equation of Haycock et al. (8).
 The coronary arterial Z-score was computed by the McCrin-
dle’s equation and Dallaire Z-scoring Calculator (9,10). The Z-
score (left main artery [LMA], left anterior descending [LAD], 
and RCA) was obtained by dividing the difference between the 
actual measurement and the predicted measurement by the SD:
LMA = 0.31747 × (BSA0.36008) − 0.02887, SD 
= 0.03040 + (0.01514 × BSA)
LAD = 0.26108 × (BSA0.37893) − 0.02852, SD 
= 0.01465 + (0.01996 × BSA)
RCA = 0.26117 × (BSA0.39992) − 0.02756, SD 
= 0.02407 + (0.01597 × BSA)
Statistical analysis
Statical analyses were performed using SAS version 9 (SAS In-
stitute, Cary, NC, USA). The statistically significant level was set 
at P < 0.05. Data were expressed as mean ± SD. The Pearson 
correlation and paired t-test were used to compare the mean 
values of echocardiographic indices between the baseline and 
long-term measurements.
Ethics statement
The present study protocol was reviewed and approved by the 
Institutional Review Board of Yonsei University College of Med-
icine (No. 2017-0108-001) with waive of informed consent.
RESULTS
A total of 67 KD patients were analysed. The mean age at the di-
agnosis of KD was 4.74 ± 2.35 years and the mean age at the fol-
low-up study was 8.6 ± 2.4 years. At the time of diagnosis, the 
average height was 117.0 ± 17.0 cm and the weight was 22.0 ±  
8.0 kg. The average height and weight at the follow-up study was 
135.0 ± 14.3 cm and 32.3 ± 10.5 kg (Table 1).
 We performed blood tests two times during the acute phase of 
KD (before the diagnosis of KD and 3 days after immunoglobulin 
administration). The mean white blood cell count was 9,910.51 ±  
4,667.57, hemoglobin was 11.94 ± 1.05, and the platelet count 
Table 1. Patient characteristic and laboratory findings
Parameters Onset of KD At follow-up study
Age, yr 4.74 ± 2.35 8.60 ± 2.40
Sex (M:F) 34:33 34:33
Height, cm 117.0 ± 17.9 135.0 ± 14.3
Weight, kg 22.00 ± 8.02 32.30 ± 10.50
BSA, m2 1.00 ± 0.21 1.09 ± 0.23
Data are shown as mean ± standard deviation.
KD = Kawasaki disease, BSA = body surface area.
Table 2. The laboratory findings at diagnosis of KD
Laboratory items Values
White blood cell, 103/μL 9,910.51 ± 4,667.57
Hemoglobin, 106/μL 11.94 ± 1.05
Hematocrit, g/dL 35.17 ± 3.25
Platelet, 103/μL 381.67 ± 112.09
Erythrocyte sedimentation rate, mm/hr 57.80 ± 33.42
C-reactive protein, mg/L 31.26 ± 41.08
Aspartate transaminase, IU/L 68.53 ± 134.18
Alanine transaminase, IU/L 48.97 ± 87.94
Creatine kinase, U/L 367.80 ± 932.12
Creatine kinase-MB fraction, μg/L 3.35 ± 6.88
Total billirubin, mg/dL 0.35 ± 0.24
Cholesterol, mg/dL 141.39 ± 26.39
Lactic dehydrogenase, IU/L 611.93 ± 429.91
Troponin T, μg/L 0.001 ± 0.002
BNP, pg/mL 30.46 ± 45.60
Data are shown as mean± standard deviation.
KD = Kawasaki disease, BNP = brain natriuretic peptide.
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was 381,670 ± 112,090. The mean erythrocyte sedimentation 
rate was 57.8 ± 33.42 mm/hr and the mean C-reactive protein 
was 31.26 ± 41.08 mg/dL (Table 2).
 Table 3 shows echocardiographic findings of KD patients. In-
terventricular septum thickness at end-diastole (IVSd; 6.17 ± 1.08 
mm at baseline vs. 6.55 ± 1.31 mm at follow-up, P = 0.005), LVIDs 
(23.4 ± 3.08 mm at baseline vs. 25.4 ± 3.20 mm at follow-up, P =  
0.003), maximal velocity of late diastolic filling across mitral 
valve (mitral A) flow (0.53 ± 0.18 m/s at baseline vs. 0.47 ± 0.10 
m/s at follow-up, P = 0.006), maximal velocity of early diastolic 
filling across mitral valve (mitral E)/A ratio (2.07 ± 0.51 at base 
line vs. 2.27 ± 0.53 at follow-up, P = 0.008), mitral E wave to peak 
early diastolic tissue wave (E/E’) ratio (7.14 ± 1.63 at base line 
vs. 6.93 ± 1.41 at follow-up, P = 0.013) showed significant differ-
ences in the follow-up study. LVEF, LVFS, interventricular sep-
tum thickness at end-systole (IVSs), LVIDd, LV posterior wall 
thickness at end-diastole (LVPWd), LV posterior wall thickness 
at end-systole (LVPWs), mitral E flow, mean value theorem for 
derivatives (MVTD), peak early diastolic tissue (E’), peak late 
diastolic tissue (A’), peak systolic tissue (S’) showed no signifi-
cant differences. Table 4 shows coronary Z-scores of KD patients. 
The LMA, LAD, and RCA showed no statistically significant dif-
ferences. But delta value of LMA, LAD, and RCA showed signif-
icant differences in the follow-up study.
DISCUSSION
The long-term cardiovascular outcome of KD is an important 
concern. Coronary artery aneurysm can be developed in 20%–
25% of untreated patients, and 5% of treated patients. Giant an-
eurysms can cause coronary artery stenosis and increase the 
risk of myocardial infarction or death (11). Severe coronary ar-
tery disease can develop into coronary stenosis, which can lead 
to acute myocardial infarction. Coronary aneurysms, greater 
than 6 mm, are highly likely to cause myocardial ischemia. Oth-
er inflammatory heart diseases, such as myocarditis, endocar-
ditis, valvulitis and pericarditis are also common during the 
acute phase of KD. The characteristics of myocarditis in KD are 
1) mild decrease in LV systolic function, 2) transient pericardial 
effusion, 3) transient inflammatory changes in cardiac valves, 
and 4) mild or no symptoms. The severity of myocardial dysfunc-
tion is associated with myocardial inflammation. More than 
Table 3. Echocardiographic indices in the KD patients with diastolic data
Indices Initial Follow-up data P value r
LVEF, % 66.54 ± 4.96 65.48 ± 5.11 0.390 0.15
LVFS, % 45.62 ± 52.65 35.55 ± 3.92 0.900 −0.02
IVSd, mm 6.17 ± 1.08 6.55 ± 1.31 0.005 0.51
IVSs, mm 8.09 ± 1.41 8.72 ± 1.48 0.010 0.45
LVIDd, mm 35.90 ± 4.34 39.00 ± 3.87 0.210 0.23
LVIDs, mm 23.41 ± 3.08 25.31 ± 3.20 0.003 0.52
LVPWd, mm 5.69 ± 1.38 5.74 ± 1.24 0.250 0.22
LVPWs, mm 8.60 ± 1.41 9.09 ± 1.70 0.270 0.21
Mitral E, m/s 1.02 ± 0.29 1.03 ± 0.15 0.760 0.053
Mitral A, m/s 0.53 ± 0.18 0.47 ± 0.10 0.006 0.46
Mitral E/A 2.07 ± 0.51 2.27 ± 0.53 0.008 0.44
DT, m/s 128.88 ± 29.20 146.10 ± 27.78 0.320 0.23
Doppler velocity of mitral annulus, m/s
   E' 0.15 ± 0.02 0.15 ± 0.03 0.110 0.28
   A' 0.09 ± 0.11 0.06 ± 0.01 0.790 −0.05
   S' 0.11 ± 0.16 0.07 ± 0.02 0.060 0.35
E/E' 7.15 ± 1.63 6.93 ± 1.41 0.013 0.46
Data are shown as mean ± standard deviation.
KD = Kawasaki disease, LVEF = left ventricular ejection fraction, LVFS = left ventricular fraction shortening, IVSd = interventricular septum thickness at end-diastole, IVSs = inter-
ventricular septum thickness at end-systole, LVIDd = left ventricular internal diameters at end-diastolic, LVIDs = left ventricular internal diameters at end-systolic, LVPWd = left 
ventricular posterior wall thickness at end-diastole, LVPWs = left ventricular posterior wall thickness at end-systole, mitral E = maximal velocity of early diastolic filling across 
mitral valve, mitral A = maximal velocity of late diastolic filling across mitral valve, mitral E/A = ratio of mitral E to A waves, DT = mitral valvular deceleration time, E' = peak 
early diastolic tissue, A' = peak late diastolic tissue, S' = peak systolic tissue, E/E' = ratio of mitral E to E' waves.
Table 4. Echocardiographic findings of coronary arteries
Findings Initial data Follow-up data P value r Delta value* SD P value
LMA (Z) 3.01 ± 0.20 0.65 ± 0.86 0.415 −0.174 −2.48 1.99 < 0.001
LAD (Z) 1.70 ± 1.07 0.55 ± 0.91 0.739 0.072 −0.92 1.33 0.003
RCA (Z) 0.82 ± 1.35 0.15 ± 0.77 0.688 −0.086 −0.91 1.50 0.007
LMA = left main artery, LAD = left anterior descending, RCA = right coronary artery, SD = standard deviation.
*Delta value: mean differences between initial and follow-up data.
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50% of patients with KD have myocarditis showing symptoms, 
electrocardiogram changes, and echocardiographic changes 
within the first 3 weeks. Inflammatory myocardial changes can 
be detected with gallium-67 cardiac scan or Tc-99m labeled car-
diac scan (12).
 Deteriorated LV contractility can be improved after adminis-
tration of intravenous immunoglobulin (13-15). Kurotobi et al. 
(16) reported LV diastolic dysfunction in children with acute 
KD, which may be associated with increased brain natriuretic 
peptide (BNP) levels. Arnold et al. (17) examined asymptomatic 
children with persistent coronary artery lesions after KD, and 
revealed diastolic dysfunction in the segments supplied by ste-
notic coronary arteries under conditions of exercise. Takeuchi 
et al. (18) reported decreased E’ and increased E/E’ ratio in the 
tissue Doppler study in the acute phase of KD, which were nor-
malized in the convalescent phase. The BNP levels were signifi-
cantly associated with velocity of circumferential fiber shorten-
ing and S’ at the lateral mitral annulus in the tissue Doppler study, 
but not significantly associated with E′ lateral, E/E′, and E/A ra-
tios. Selamet Tierney et al. (19) demonstrated decreased E’ and 
impaired diastolic function in patients with coronary artery an-
eurysms. Decreased diastolic function may result in the increased 
BNP level. Most of previous studies on myocardial dysfunction 
in KD were performed in the acute phase of KD. The long-term 
follow-up study on myocardial function in KD had rarely been 
reported.
 We performed a long-term follow-up study on the second-
grade elementary school children who had been treated due to 
KD, including investigation of myocardial function. In the result 
of our study, the diastolic function was within reasonable rang-
es both in the acute phase and long-term follow-up period. How-
ever, there were significant differences in diastolic parameters, 
such as mitral A flow, mitral E/A, and E/E’ ratios. The decreased 
E/A ratio is an expected finding in the presence of impaired re-
laxation, which slows diastolic tissue velocity (20). As a result, 
the blood flow from the atrium to the ventricle is delayed and 
the duration of diastole is prolonged. Defects in the diastolic 
phase in these patients may create small changes in the myo-
cardial blood flow and reflect inflammatory changes in myo-
cardium and coronary arteries (21).
 The mean LMA Z-score in the acute phase was 3.1 and de-
creased to 0.6 at the time of study, but it was not statistically sig-
nificant. However, the delta values of individual coronary artery 
Z-score changes were statistically significant. Some of echocar-
diographic measurements, such as IVSd, LVIDs, mitral A flow, 
mitral E/A, and E/E’ ratios, showed statistically significant dif-
ferences in the follow-up period. Therefore, the follow-up echo-
cardiography should be performed to ensure that the relaxation 
function be improved again. Currently, the follow-up guidelines 
of KD are mainly based on the presence of coronary artery an-
eurysms. Children without coronary artery aneurysms have 
been followed up for less than 2 years in many hospitals. How-
ever, we think that even though the follow-up echocardiogra-
phy is normal, significant alteration or reductions in myocardial 
function may be present. We intend to follow-up these patients 
after three and five years and see if functional abnormalities 
will be recovered. We think that the follow-up guidelines of KD 
need to be elaborated with respect to the diastolic function and 
the follow-up period.
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